Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,841
Sort by:
Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets 2021: Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Landscape
US$ 4,850.00
... diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...
September 2017
495 pages
Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets 2021: Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Landscape
US$ 8,750.00
... diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...
September 2017
570 pages
U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets 2021: Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Landscape
US$ 1,850.00
... diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...
September 2017
408 pages
U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets 2021: Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Landscape
US$ 2,750.00
... diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...
September 2017
430 pages
Aeromonads Diagnostic Testing Market 2021: Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,350.00
... analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology ... provides the 5-year test volume and sales forecasts by country for the following market segments: Hospitals Commercial/Private ...
September 2017
200 pages
Clostridium Testing Market 2021: Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,350.00
The report presents a detailed analysis of the Clostridium diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. ... Clostridium definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market ...
September 2017
225 pages
Cryptosporidium Testing Market 2021: Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,350.00
The report presents a detailed analysis of the Cryptosporidium diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and ... Cryptosporidium definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market ...
September 2017
207 pages
E. Coli Testing Market 2021: Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,350.00
... contains 200 pages, 7 tables and presents a detailed analysis of the E. Coli diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan ... . The report provides the 5-year test volume and sales forecasts by country for the following market segments: Hospitals Commercial/Private Labs ...
September 2017
200 pages
Malaria Testing Market 2021: Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,350.00
The report presents a detailed analysis of the Malaria diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current ... Malaria definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market ...
September 2017
191 pages
Pseudomonas Testing Market 2021: Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,350.00
The report presents a detailed analysis of the Pseudomonas diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. ... Pseudomonas definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market ...
September 2017
198 pages
Rhinovirus Testing Market 2021: Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,350.00
The report presents a detailed analysis of the Rhinovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current ... Rhinovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market ...
September 2017
194 pages
